Qinghao Zhao

Qinghao Zhao

Auto-generated profile, based on publicly available information

Qinghao Zhao

Department of Orthopedics, the Third Affiliated Hospital of Southern Medical University, Guangzhou, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2019 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
LYLianjun Yang
Lianjun Yang
BLBin Liu
Bin Liu
JZJunchi Zheng
Junchi Zheng
JHJincheng Huang
Jincheng Huang
QZQinghao Zhao
Qinghao Zhao
HLHai Lu
Hai Lu
Recently, accumulating evidence has suggested that gut microbiota may be involved in the occurrence and development of ankylosing spondylitis (AS). It has been suggested that rifaximin have the ability to modulate the gut bacterial communities, prevent inflammatory response, and modulate gut barrier function. The goal of this work is to evaluate the protective effects of rifaximin in fighting AS and to elucidate the potential underlying mechanism. Rifaximin were administered to the proteoglycan (PG)-induced AS mice for 4 consecutive weeks. The disease severity was measured with the clinical and histological of arthritis and spondylitis. Intestinal histopathological, pro-inflammatory cytokine levels and the intestinal mucosal barrier were evaluated. Then, western blot was performed to explore the toll-like receptor 4 (TLR-4) signal transducer and NF-κB expression. Stool samples were collected to analyze the differences in the gut microbiota via next-generation sequencing of 16S rDNA. We found that rifaximin significantly reduced the severity of AS and resulted in down-regulation of inflammatory factors, such as TNF-α, IL-6, IL-17A, and IL-23. Meanwhile, rifaximin prevented ileum histological alterations, restored intestinal barrier function and inhibited TLR-4/NF-κB signaling pathway activation. Rifaximin also changed the gut microbiota composition with increased Bacteroidetes/Firmicutes phylum ratio, as well as selectively promoting some probiotic populations, including Lactobacillales. Our results suggest that rifaximin suppressed progression of AS and regulated gut microbiota in AS mice. Rifaximin might be useful as a novel treatment for AS.


26 September 2019 in Microbiologyopen
Verified
Journal Article
Open access
PDF file
BLBin Liu
Bin Liu
LYLianjun Yang
Lianjun Yang
ZCZhifei Cui
Zhifei Cui
JZJunchi Zheng
Junchi Zheng
JHJincheng Huang
Jincheng Huang
HLHai Lu
Hai Lu
Ankylosing spondylitis is a chronic, progressive disease, and its treatment is relevant to the gut microbiota. Anti‐tumor necrosis factor‐alpha (anti‐TNF‐α) therapy alters the gut microbiota in many diseases, including inflammatory bowel disease. However, little is known about the effect of TNF‐α blocker treatment on the gut microbiota in ankylosing spondylitis. Herein, the effect of a TNF‐α blocker on the gut microbiota in proteoglycan‐induced arthritis was investigated. Proteoglycan‐induced mice were treated with an rhTNFR:Fc solution of etanercept (5 µg/g) for 4 weeks. rhTNFR:Fc treatment attenuated the arthritis incidence and severity of arthritis in the proteoglycan‐induced mice and decreased inflammation in the ankle joints and ameliorated ileal tissue destruction. Moreover, high gut permeability occurred, and zonula occludens‐1 and occludin protein levels were reduced in proteoglycan‐induced mice. These levels were significantly restored by the administration of rhTNFR:Fc. The serum TNF‐α and IL‐17 levels were also decreased. In addition, flora analysis via 16S rDNA high‐throughput sequencing revealed that rhTNFR:Fc treatment restored the gut microbiota composition to a composition similar to that in control mice. In conclusion, anti‐TNF‐α therapy attenuated proteoglycan‐induced arthritis progression and modulated the gut microbiota and intestinal barrier function. These results provide new insights for anti‐TNF‐α therapy strategies via regulating the gut microbiota in ankylosing spondylitis.

15 January 2020 in Spine
Verified
Journal Article
Closed access
QZQinghao Zhao
Qinghao Zhao
LCLiang Cheng
Liang Cheng
HYHuibo Yan
Huibo Yan
SDShangxi Deng
Shangxi Deng
JZJianjun Zhao
Jianjun Zhao
QLQingchu Li
Qingchu Li
Study Design.: A dissection-based study of 10 embalmed human cadavers. Objective.: The purpose of this study was to describe the sinuvertebral nerves at the lumbar level and to discuss their possible clinical significance. Summary of Background Data.: Discogenic low-back pain is mediated by the sinuvertebral nerves. However, the detailed descriptions of the sinuvertebral nerves at the lumbar level are lacking. Methods.: One hundred L1-L5 intervertebral foramina from 10 embalmed cadavers were studied. The presence of the sinuvertebral nerves was noted. The quantity, origin, pathway, innervation range, and spatial orientations of the sinuvertebral nerves in the L1-L5 intervertebral foramina were examined. Results.: A total of 450 sinuvertebral nerves were identified in the 100 lumbar intervertebral foramina; sinuvertebral nerves were observed in 100.00% of the intervertebral foramina. The sinuvertebral nerves were routinely divided into the following two types: the sinuvertebral nerve deputy branch and sinuvertebral nerve main trunk. Three hundred twelve sinuvertebral nerve deputy branches were found; on average, there were approximately 3.12 (range, 1–8) branches in each intervertebral foramen. One hundred thirty-eight sinuvertebral nerve main trunks were found, and sinuvertebral nerve main trunks were observed in 97.00% of the intervertebral foramina. The initial portion of the sinuvertebral nerve was located along the posterior-lateral edge of the disc to the spinal canal. Sixty-one (44.20%) sinuvertebral nerve main trunks originated from the starting point of the gray ramus communicans of the nerve root; 77 (55.80%) sinuvertebral nerve main trunks originated from the anterior surface of the spinal ganglia of the nerve root. Conclusion.: This is a systematic anatomy study that describes the sinuvertebral nerve at the lumbar level and may be of clinical importance to spinal surgeons. A comprehensive understanding of the distribution of sinuvertebral nerves may lead to significant benefits for patients undergoing percutaneous endoscopic treatment for discogenic low-back pain. Level of Evidence: 4

1 August 2016 in The Spine Journal
Verified
Journal Article
Closed access
QZQinghao Zhao
Qinghao Zhao
EZEnyi Zhong
Enyi Zhong
BSBenchao Shi
Benchao Shi
YLYang Li
Yang Li
CSChao Sun
Chao Sun
ZDZihai Ding
Zihai Ding

1 November 2020 in The Spine Journal
Verified
Journal Article
Closed access
JZJianjun Zhao
Jianjun Zhao
QZQinghao Zhao
Qinghao Zhao
ZLZezheng Liu
Zezheng Liu
SDShanxi Deng
Shanxi Deng
LCLiang Cheng
Liang Cheng
QLQingchu Li
Qingchu Li